title: Development of rational drug combinations with investigational targeted agents.
authors.affiliation: Lance Armstrong Foundation, Austin, Texas, USA.
authors.forename: Adam
authors.initials: A
authors.lastname: Clark
authors.forename: Matthew
authors.initials: M
authors.lastname: Ellis
authors.forename: Charles
authors.initials: C
authors.lastname: Erlichman
authors.forename: Stuart
authors.initials: S
authors.lastname: Lutzker
authors.forename: James
authors.initials: J
authors.lastname: Zwiebel
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000592:standards*; D017322:Clinical Trials, Phase II as Topic / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000592:standards; D004357:Drug Synergism; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational